Synexa Insights
The Latest Insights From Our Scientists
Beyond Weight Loss: How Incretins Are Redefining Obesity Drug Development
Incretin therapies are changing obesity treatment. Discover why future obesity drug development will be defined by outcomes beyond weight loss.…
Why Preclinical Formulation Analysis is Critical to Successful Drug Development
Preclinical studies are designed to establish the safety profile and biological activity of a therapeutic candidate before human testing can…
GMP Potency Assays: Technologies & Validation Guide
Following up on our previous GMP blog “GMP Grade Ligand Binding and Potency Assays – Frequently Asked Questions”, this article…
Antibody‑Drug Conjugates (ADCs): The Tipping Point
The field of antibody-drug conjugates (ADCs) is entering an exciting era, and there is no shortage of writing today about…
From Detection to Decision: Risk-Based Immunogenicity Testing
Immunogenicity describes treatment‑induced B‑ and T‑cell responses to therapeutics and represents a major hurdle for drug development, due to the…
From Discovery to Decision: Building a Fit-for-Purpose Proteomics Strategy for Clinical Development
Late-stage clinical trial attrition remains one of the most expensive challenges in drug development, with more than half of Phase…
Protein Degraders: Small Molecules Taking out the Trash
A single PROTAC molecule has two different binding ligands attached by a linker. One ligand binds to the target protein…
A Practical Guide to Biomarkers for Clinical Development
Biomarker solutions cover a range of technologies, from modern diagnostic tools which make biological traits accessible, to analytical systems underpinning…
How to Accelerate Preclinical Trials with Flow Cytometry
Flow cytometry is a powerful analytical method for various applications in preclinical and clinical research. It is used in cell…
Navigating IVDR in Clinical Trials: What’s Changed, and Why It Matters
Over the holidays, the European Commission released amendments to the IVDR that could materially change how clinical trial biomarker testing…
Where Does Bioanalysis Fit into Drug Discovery Pipelines?
Bioanalysis is foundational for investigational therapeutic agents. This blog post will define the bioanalysis of molecules and highlight its beneficial…
EBF OS 2025: My Key Highlights
A unifying message across EBF 2025 was that bioanalytical science is transitioning from technical execution to decision support. For years,…
S-Pindolol: Combatting Cancer Cachexia Effectively
Cancer cachexia is a silent thief. It robs patients of strength, stripping away muscle and fat, leaving them frail and…
Improving the quality of human health
Contact us
Discuss biomarker and bioanalytical solutions to accelerate your therapeutic pipeline
